Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interferon gamma plus anidulafungin for candidemia
NL-OMON35641Phase 3Recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Jan 2011
- Modality
- Cyclic Peptides → Modified Peptides → Peptides, Small Molecules, Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of interferon gamma-1b and anidulafungin in candidemia and invasive candidiasis (2 arms), sponsored by Radboud University Medical Center. Primary endpoint: Time to negative blood cultures. Started Jan 2011; status: recruiting.
02
Drugs
interferon gamma-1banidulafungin
03
Conditions
candidemiainvasive candidiasis
Beyond the preview
Go deeper on NL-OMON35641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35641.